Get started
Author

Elsa Fragoso

COPD and Cardiovascular Disease
2018 · S. André, B. Conde, et al. · Pulmonology · 210
Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
2020 · Liesbet De Bus, Pieter Depuydt, et al. · Intensive Care Medicine · 124
Understanding COPD: A vision on phenotypes, comorbidities and treatment approach
2016 · E. Fragoso, S. André, et al. · Revista Portuguesa de Pneumologia · 37
PDF
Effects of Occupational Exposure to Tobacco Smoke: Is There a Link Between Environmental Exposure and Disease?
2013 · Solange A. Pacheco, Vukosava M. Torres, et al. · Journal of Toxicology and Environmental Health · 24
Role of Fiberoptic Bronchoscopy in Intensive Care Unit: Current Practice
2011 · Elsa Guerreiro da Cunha Fragoso, José Manuel Rosal Gonçalves · Journal of Bronchology & Interventional Pulmonology · 21
The suitability of EBC-Pb as a new biomarker to assess occupational exposure to lead
2014 · Pedro M. Félix, Susana Marta Almeida, et al. · International Journal of Environmental Health Research · 11
Derrame pleural recidivante e polipose gástrica – Caso clínico
2009 · E. Fragoso, I. Correia, et al. · Revista Portuguesa de Pneumologia · 2
PDF
Impact of elexacaftor/tezacaftor/ivacaftor on the small airways in cystic fibrosis
2025 · Sofia Campos Silva1, Andreia Barroso2, et al. · Jornal Brasileiro de Pneumologia · 1
PDF
P074 Long-term safety and effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI): A 48-week observational study in a single Reference Centre
2024 · E. Fragoso, M. Nunes, et al. · Journal of Cystic Fibrosis · 1
Is there a role for sweat chloride levels as a marker of clinical response to Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis patients?
2023 · Rudi Mauro Pereira Fernandes, Elsa Fragoso, et al. · 1
Airway microbiology trends in Cystic Fibrosis patients: A comparative study between 2019 and 2023
2025 · Francisca Trigueiros Pinção Nieto Guimarães, Elsa Fragoso, et al. · European Respiratory Journal
854 People with CF not eligible for CFTR modulators in a Portuguese CF reference center: a snapshot
2024 · E. Fragoso, C. Constant, et al. · Journal of Cystic Fibrosis
Long-term effectiveness and safety of Elexacaftor/Tezacaftor/Ivacaftor in daily practice of a Portuguese Cystic Fibrosis Reference Centre
2023 · Rudi Mauro Pereira Fernandes, Elsa Fragoso, et al.
Risk Factors for Multidrug-resistant Bacteria in a Respiratory Intensive Care Unit
2020 · Marcos Oliveira, Carlos Lopes, et al. · European Respiratory Journal
Natriuretic peptide as a prognostic biomarker in septic shock in respiratory intensive care
2013 · Carlos Lopes, Sara Carvalho, et al. · European Respiratory Journal
Outcome of respiratory critical care patients treated with noninvasive ventilation as a maximal intervention strategy
2012 · Elsa Fragoso, Filipe Monteiro, et al. · European Respiratory Journal
Tobacco Smoke Occupational Exposure: Biomarkers of Biological Damage
2011 · Tânia Simões, Vukosava D. Milic, et al. · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
[Minimally invasive thoracic surgery: a fifteen-years experience].
2010 · E Fragoso, J Cruz, et al. · PubMed
Insuficiencia cardiaca (ic)
1981 · S Murad-Netto, Elsa Fragoso, et al. · Ars Cvrandi
Works count: 19
Citation count: 432
H-index: 6
I10-index: 6
Year
Topic
Type